Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (331-340 of 4,097) with videos related to

Pageof 410
Sort By:
Cancer Cell|March 16, 2010
The rebirth of a phoenix: ovarian cancers are addicted to ErbB-3Gordon B Mills, Yosef Yarden
Cancer Cell|February 5, 2010
A tumor suppressor SIRTaintyPaul T Schumacker
Cancer Cell|February 5, 2010
SUMO boosts the DNA damage response barrier against cancerJiri Bartek, Zdenek Hodny
Cancer Cell|February 5, 2010
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, et al.
Cancer Cell|February 9, 2010
FcRgamma activation regulates inflammation-associated squamous carcinogenesisPauline Andreu, Magnus Johansson, Nesrine I Affara, et al.
Cancer Cell|May 10, 2017
RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal MelanomaXu Chen, Qiuxia Wu, Philippe Depeille, et al.
Cancer Cell|April 17, 2018
The Intestinal Microbiota in Colorectal CancerHerbert Tilg, Timon E Adolph, Romana R Gerner, et al.
Cancer Cell|April 17, 2018
The Platelet Lifeline to Cancer: Challenges and OpportunitiesMonika Haemmerle, Rebecca L Stone, David G Menter, et al.
Cancer Cell|April 11, 2018
More Rules, Still Exceptions: Understanding Immunomodulatory Antibody Activity In VivoAndrea Ipsen-Escobedo, Falk Nimmerjahn
Cancer Cell|April 11, 2018
T Cell Dysfunction in CancerDaniela S Thommen, Ton N Schumacher
Pageof 410

Showing results (331-340 of 4,097) with videos related to

Sort By:
Pageof 410
Cancer Cell|March 16, 2010
The rebirth of a phoenix: ovarian cancers are addicted to ErbB-3Gordon B Mills, Yosef Yarden
Cancer Cell|February 5, 2010
A tumor suppressor SIRTaintyPaul T Schumacker
Cancer Cell|February 5, 2010
SUMO boosts the DNA damage response barrier against cancerJiri Bartek, Zdenek Hodny
Cancer Cell|February 5, 2010
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, et al.
Cancer Cell|February 9, 2010
FcRgamma activation regulates inflammation-associated squamous carcinogenesisPauline Andreu, Magnus Johansson, Nesrine I Affara, et al.
Cancer Cell|May 10, 2017
RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal MelanomaXu Chen, Qiuxia Wu, Philippe Depeille, et al.
Cancer Cell|April 17, 2018
The Intestinal Microbiota in Colorectal CancerHerbert Tilg, Timon E Adolph, Romana R Gerner, et al.
Cancer Cell|April 17, 2018
The Platelet Lifeline to Cancer: Challenges and OpportunitiesMonika Haemmerle, Rebecca L Stone, David G Menter, et al.
Cancer Cell|April 11, 2018
More Rules, Still Exceptions: Understanding Immunomodulatory Antibody Activity In VivoAndrea Ipsen-Escobedo, Falk Nimmerjahn
Cancer Cell|April 11, 2018
T Cell Dysfunction in CancerDaniela S Thommen, Ton N Schumacher
Pageof 410